Express Scripts Holding Company (ESRX) is a pharmacy benefit management organization that provides services to over 80 million customers in the United States and abroad. The company works with pharmaceutical manufacturers to develop cost-effective prescription drug programs, and it provides services such as mail order and specialty pharmacy services. ESRX is one of the largest pharmaceutical benefit management companies in the United States, and its stock price has seen a lot of movement over the past few years.
ESRX Stock Price History
The stock price of ESRX has seen a significant rise since the start of 2021. At the beginning of the year, the stock was trading at around $65 per share. By mid-February, the stock had risen to over $80 per share, and it has continued to climb since then. As of April 2021, the stock is trading at around $90 per share. This represents an increase of almost 40% since the start of the year.
The stock price of ESRX has been volatile over the past few years. In 2020, the stock started the year at around $90 per share and saw a sharp decline in the first quarter due to the COVID-19 pandemic. The stock bottomed out at around $58 per share in March 2020 before recovering to around $70 per share by the end of the year. This represents a decline of over 20% for the year.
In 2019, the stock started the year at around $80 per share and ended the year at around $90 per share. This represents an increase of almost 13% for the year. Over the past five years, the stock has seen an average annual return of around 14%.
Factors Affecting ESRX Stock Price
The stock price of ESRX has been affected by a variety of factors over the past few years. One of the most significant factors has been the impact of the COVID-19 pandemic. The pandemic caused a sharp decline in the stock price of ESRX in the first quarter of 2020, and it has taken the stock a few months to recover from the impact of the pandemic.
In addition, the stock price of ESRX has been affected by the performance of the company's competitors. The company's competitors, such as CVS Health Corporation (CVS), have seen significant gains in their stock price in recent years. This has put pressure on ESRX to keep up with the competition.
Finally, the stock price of ESRX has been affected by the performance of the overall stock market. The stock market has been volatile in recent years, and this has had an impact on the stock price of ESRX. In 2020, the stock market saw a sharp decline due to the pandemic, and this had a negative impact on the stock price of ESRX.
ESRX Stock Price Forecast
It is difficult to accurately predict the future stock price of ESRX. The stock price is affected by a variety of factors, and it is impossible to predict how these factors will play out in the future. However, analysts generally expect the stock price of ESRX to continue to rise in the coming years. Analysts believe that the company will benefit from the increasing demand for its services, as well as from the positive impact of the COVID-19 vaccine.
In addition, analysts expect the stock price of ESRX to continue to be affected by the performance of its competitors. The company's competitors, such as CVS, will likely continue to put pressure on ESRX to keep up with the competition. Finally, the stock price of ESRX will also be affected by the performance of the overall stock market.
Conclusion
The stock price of ESRX has seen a significant rise in 2021 and is currently trading at around $90 per share. The stock price has been affected by a variety of factors, including the impact of the COVID-19 pandemic, the performance of the company's competitors, and the performance of the overall stock market. Analysts generally expect the stock price of ESRX to continue to rise in the coming years.